June 16, 2014 Press release Mitsubishi Tanabe Pharma Corporation Positive Phase 3 Results of Canagliflozin in Japanese Patients with Type 2 Diabetes at American Diabetes Association - Canagliflozin - Document - PDFSEARCH.IO

First Page	Meta Content
	June 16, 2014 Press release Mitsubishi Tanabe Pharma Corporation Positive Phase 3 Results of Canagliflozin in Japanese Patients with Type 2 Diabetes at American Diabetes Association Add to Reading List Document Date: 2014-06-15 21:20:21 Open Document File Size: 45,26 KB Share Result on Facebook City San Francisco / / Company Mitsubishi Tanabe Pharma Corporation / / Country Japan / United States / / Event FDA Phase / / MedicalCondition genital mycotic infections / Diabetes / / Organization American Diabetes Association Osaka / / Person Michihiro Tsuchiya / / / Position Director / CEO / President & Representative / / Product Canagliflozin / / SocialTag Medicine Diabetes management Glycated hemoglobin Diabetes mellitus type 2 Diabetes mellitus Diabetes Endocrine system Health

June 16, 2014 Press release Mitsubishi Tanabe Pharma Corporation Positive Phase 3 Results of Canagliflozin in Japanese Patients with Type 2 Diabetes at American Diabetes AssociationAdd to Reading List